Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-10-17 00:00:00 ET · period of report 2024-10-15 · accession 0001628280-24-043067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-17 | 2024-10-15+ | BLFS | Mathew Aby J. | EVP, CSO | M - OptEx | $2.06 | +20.0K | 327.7K | +6% | +$41.2K |
| DM | 2024-10-17 | 2024-10-15+ | BLFS | Mathew Aby J. | EVP, CSO | S - Sale+OE | $23.23 | -20.0K | 317.7K | -6% | -$464.5K |
| DM | 2024-10-17 | 2024-10-15+ | BLFS | Mathew Aby J. | EVP, CSO | M - OptEx | $0.00 | -20.0K | 20.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-15 | M | A | 10,000 | $2.06 | 327,716 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-16 | S | D | 10,000 | $23.17 | 317,716 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.90 to $23.53, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Common Stock | 2024-10-16 | M | A | 10,000 | $2.06 | 327,716 | D | — | — | |
| 4 | Common | Common Stock | 2024-10-15 | S | D | 10,000 | $23.28 | 317,716 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.49, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Derivative | Employee Stock Option | 2024-10-16 | M | D | 10,000 | $0.00 | 10,000 | D | $2.06 · — to 2025-05-04 | 10,000 Common Stock | (F4) On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. |
| 6 | Derivative | Employee Stock Option | 2024-10-15 | M | D | 10,000 | $0.00 | 20,000 | D | $2.06 · — to 2025-05-04 | 10,000 Common Stock | (F4) On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. |